Home › Malattie polmonari › Texas › Houston
Studi clinici su Malattie polmonari a Houston, TX
15 studi su Malattie polmonari cercano partecipanti presso sedi a Houston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of COVID-19 Vaccine(s) in Children and Adults
In reclutamentoFase 3Volontari sani benvenuti
- DM Clinical Research-Cyfair, Houston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
In reclutamentoFase 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- e altri 4
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
In reclutamentoFase 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- e altri 4
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
In reclutamentoFase 2
- Baylor College of Medicine Medical Center, Houston
American Lung Association (ALA) Lung Health Cohort
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Baylor College of Medicine, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- MD Anderson, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
In reclutamentoFase 2
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Site 1005, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
In reclutamentoFase 3
- GSK Investigational Site, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
In reclutamentoFase 2
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Houston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
In reclutamentoFase 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
In reclutamentoFase 1/2
- MD Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
In reclutamento
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Studi su Malattie polmonari in altre città
- Boston, MA14 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Pittsburgh, PA11 studi
- Dallas, TX10 studi
- Nashville, TN10 studi
- Columbus, OH10 studi
- Los Angeles, CA10 studi
- Washington, DC10 studi
- Miami, FL10 studi
- Ann Arbor, MI10 studi
- Chicago, IL9 studi
Altri studi a Houston
- Cancro del polmone non a piccole cellule145 studi
- Cancro al seno126 studi
- Cancro (tutti i tipi)121 studi
- Cancro metastatico104 studi
- Cancro colorettale102 studi
- Cancro ovarico89 studi
- Leucemia mieloide acuta85 studi
- Cancro ai polmoni78 studi
- Cancro alla prostata76 studi
- Cancro dell'endometrio68 studi
- Cancro pancreatico61 studi
- Melanoma59 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.